{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T20:32:49Z","timestamp":1776025969743,"version":"3.50.1"},"publisher-location":"New York, NY, USA","reference-count":38,"publisher":"ACM","license":[{"start":{"date-parts":[[2022,11,10]],"date-time":"2022-11-10T00:00:00Z","timestamp":1668038400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.acm.org\/publications\/policies\/copyright_policy#Background"}],"content-domain":{"domain":["dl.acm.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,11,10]]},"DOI":"10.1145\/3574198.3574221","type":"proceedings-article","created":{"date-parts":[[2023,3,15]],"date-time":"2023-03-15T09:24:43Z","timestamp":1678872283000},"page":"147-154","update-policy":"https:\/\/doi.org\/10.1145\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Prediction of drug effectiveness in rheumatoid arthritis patients based on machine learning algorithms"],"prefix":"10.1145","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1556-0679","authenticated-orcid":false,"given":"Shengjia","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Radiology, New York University, Grossman School of Medicine, USA"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1455-0412","authenticated-orcid":false,"given":"Nikunj","family":"Gupta","sequence":"additional","affiliation":[{"name":"New York University, Tandon School of Engineering, USA"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7941-5545","authenticated-orcid":false,"given":"Woodward B.","family":"Galbraith","sequence":"additional","affiliation":[{"name":"New York University, Center for Data Science, USA"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2646-2591","authenticated-orcid":false,"given":"Valay","family":"Shah","sequence":"additional","affiliation":[{"name":"New York University, Courant Institute of Mathematical Sciences, USA"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7611-6961","authenticated-orcid":false,"given":"Jacopo","family":"Cirrone","sequence":"additional","affiliation":[{"name":"New York University, Center for Data Science, USA and Colton Center for Autoimmunity, New York University, Grossman School of Medicine, USA"}]}],"member":"320","published-online":{"date-parts":[[2023,3,15]]},"reference":[{"key":"e_1_3_2_1_1_1","volume-title":"Machine learning approaches to drug response prediction: challenges and recent progress. NPJ precision oncology 4, 1","author":"Adam George","year":"2020","unstructured":"George Adam , Ladislav Ramp\u00e1\u0161ek , Zhaleh Safikhani , Petr Smirnov , Benjamin Haibe-Kains , and Anna Goldenberg . 2020. Machine learning approaches to drug response prediction: challenges and recent progress. NPJ precision oncology 4, 1 ( 2020 ), 1\u201310. George Adam, Ladislav Ramp\u00e1\u0161ek, Zhaleh Safikhani, Petr Smirnov, Benjamin Haibe-Kains, and Anna Goldenberg. 2020. Machine learning approaches to drug response prediction: challenges and recent progress. NPJ precision oncology 4, 1 (2020), 1\u201310."},{"key":"e_1_3_2_1_2_1","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1002\/art.21235","article-title":"Remission and active disease in rheumatoid arthritis: defining criteria for disease activity states","volume":"52","author":"Aletaha Daniel","year":"2005","unstructured":"Daniel Aletaha , Michael\u00a0 M Ward , Klaus\u00a0 P Machold , Valerie\u00a0 PK Nell , Tanja Stamm , and Josef\u00a0 S Smolen . 2005 . Remission and active disease in rheumatoid arthritis: defining criteria for disease activity states . Arthritis & Rheumatism 52 , 9 (2005), 2625 \u2013 2636 . Daniel Aletaha, Michael\u00a0M Ward, Klaus\u00a0P Machold, Valerie\u00a0PK Nell, Tanja Stamm, and Josef\u00a0S Smolen. 2005. Remission and active disease in rheumatoid arthritis: defining criteria for disease activity states. Arthritis & Rheumatism 52, 9 (2005), 2625\u20132636.","journal-title":"Arthritis & Rheumatism"},{"key":"e_1_3_2_1_3_1","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/1529-0131(200001)43:1<22::AID-ANR4>3.0.CO;2-9","article-title":"Factors predicting response to treatment in rheumatoid arthritis: the importance of disease duration","volume":"43","author":"Anderson J","year":"2000","unstructured":"Jennifer\u00a0 J Anderson , George Wells , Arco\u00a0 C Verhoeven , and David\u00a0 T Felson . 2000 . Factors predicting response to treatment in rheumatoid arthritis: the importance of disease duration . Arthritis & Rheumatism: Official Journal of the American College of Rheumatology 43 , 1 (2000), 22 \u2013 29 . Jennifer\u00a0J Anderson, George Wells, Arco\u00a0C Verhoeven, and David\u00a0T Felson. 2000. Factors predicting response to treatment in rheumatoid arthritis: the importance of disease duration. Arthritis & Rheumatism: Official Journal of the American College of Rheumatology 43, 1 (2000), 22\u201329.","journal-title":"Arthritis & Rheumatism: Official Journal of the American College of Rheumatology"},{"key":"e_1_3_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780310302"},{"key":"e_1_3_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygeno.2009.08.008"},{"key":"e_1_3_2_1_6_1","volume-title":"Bagging predictors. Machine learning 24, 2","author":"Breiman Leo","year":"1996","unstructured":"Leo Breiman . 1996. Bagging predictors. Machine learning 24, 2 ( 1996 ), 123\u2013140. Leo Breiman. 1996. Bagging predictors. Machine learning 24, 2 (1996), 123\u2013140."},{"key":"e_1_3_2_1_7_1","volume-title":"The impact of rheumatoid arthritis and biologics on employers and payers. Biotechnology healthcare 5, 2","author":"Chaudhari Paresh","year":"2008","unstructured":"Paresh Chaudhari . 2008. The impact of rheumatoid arthritis and biologics on employers and payers. Biotechnology healthcare 5, 2 ( 2008 ), 37. Paresh Chaudhari. 2008. The impact of rheumatoid arthritis and biologics on employers and payers. Biotechnology healthcare 5, 2 (2008), 37."},{"key":"e_1_3_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1145\/2939672.2939785"},{"key":"e_1_3_2_1_9_1","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/00126334-200301010-00014","article-title":"Improved classification of recent HIV-1 infection by employing a two-stage sensitive\/less-sensitive test strategy","volume":"32","author":"Constantine T","year":"2003","unstructured":"Niel\u00a0 T Constantine , Anne\u00a0 M Sill , Noreen Jack , Kristen Kreisel , Jeffrey Edwards , Thomas Cafarella , Harry Smith , Courtenay Bartholomew , Farley\u00a0 R Cleghorn , and William\u00a0 A Blattner . 2003 . Improved classification of recent HIV-1 infection by employing a two-stage sensitive\/less-sensitive test strategy . JAIDS Journal of Acquired Immune Deficiency Syndromes 32 , 1 (2003), 94 \u2013 103 . Niel\u00a0T Constantine, Anne\u00a0M Sill, Noreen Jack, Kristen Kreisel, Jeffrey Edwards, Thomas Cafarella, Harry Smith, Courtenay Bartholomew, Farley\u00a0R Cleghorn, and William\u00a0A Blattner. 2003. Improved classification of recent HIV-1 infection by employing a two-stage sensitive\/less-sensitive test strategy. JAIDS Journal of Acquired Immune Deficiency Syndromes 32, 1 (2003), 94\u2013103.","journal-title":"JAIDS Journal of Acquired Immune Deficiency Syndromes"},{"key":"e_1_3_2_1_10_1","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1002\/art.30155","article-title":"The lifetime risk of adult-onset rheumatoid arthritis and other inflammatory autoimmune rheumatic diseases","volume":"63","author":"Crowson S","year":"2011","unstructured":"Cynthia\u00a0 S Crowson , Eric\u00a0 L Matteson , Elena Myasoedova , Clement\u00a0 J Michet , Floranne\u00a0 C Ernste , Kenneth\u00a0 J Warrington , John\u00a0 M Davis\u00a0III, Gene\u00a0 G Hunder , Terry\u00a0 M Therneau , and Sherine\u00a0 E Gabriel . 2011 . The lifetime risk of adult-onset rheumatoid arthritis and other inflammatory autoimmune rheumatic diseases . Arthritis & Rheumatism 63 , 3 (2011), 633 \u2013 639 . Cynthia\u00a0S Crowson, Eric\u00a0L Matteson, Elena Myasoedova, Clement\u00a0J Michet, Floranne\u00a0C Ernste, Kenneth\u00a0J Warrington, John\u00a0M Davis\u00a0III, Gene\u00a0G Hunder, Terry\u00a0M Therneau, and Sherine\u00a0E Gabriel. 2011. The lifetime risk of adult-onset rheumatoid arthritis and other inflammatory autoimmune rheumatic diseases. Arthritis & Rheumatism 63, 3 (2011), 633\u2013639.","journal-title":"Arthritis & Rheumatism"},{"key":"e_1_3_2_1_11_1","volume-title":"Philip\u00a0V Gardiner, Annette Szumski, Lisa Marshall, and Eustratios Bananis.","author":"Fleischmann M","year":"2017","unstructured":"Roy\u00a0 M Fleischmann , D\u00e9sir\u00e9e van\u00a0der Heijde , Philip\u00a0V Gardiner, Annette Szumski, Lisa Marshall, and Eustratios Bananis. 2017 . DAS28-CRP and DAS28-ESR cut-offs for high disease activity in rheumatoid arthritis are not interchangeable. RMD open 3, 1 (2017), e000382. Roy\u00a0M Fleischmann, D\u00e9sir\u00e9e van\u00a0der Heijde, Philip\u00a0V Gardiner, Annette Szumski, Lisa Marshall, and Eustratios Bananis. 2017. DAS28-CRP and DAS28-ESR cut-offs for high disease activity in rheumatoid arthritis are not interchangeable. RMD open 3, 1 (2017), e000382."},{"key":"e_1_3_2_1_12_1","first-page":"151","article-title":"Disease activity scores using C-reactive protein: CRP may replace ESR in the assessment of RA disease activity","volume":"62","author":"Fransen J","year":"2004","unstructured":"J Fransen , PM Welsing , RM De\u00a0Keijzer , and PLCM Van\u00a0Riel . 2004 . Disease activity scores using C-reactive protein: CRP may replace ESR in the assessment of RA disease activity . Ann Rheum Dis 62, Suppl 1 (2004), 151 . J Fransen, PM Welsing, RM De\u00a0Keijzer, and PLCM Van\u00a0Riel. 2004. Disease activity scores using C-reactive protein: CRP may replace ESR in the assessment of RA disease activity. Ann Rheum Dis 62, Suppl 1 (2004), 151.","journal-title":"Ann Rheum Dis"},{"key":"e_1_3_2_1_13_1","unstructured":"Yoav Freund Robert\u00a0E Schapire 1996. Experiments with a new boosting algorithm. In icml Vol.\u00a096. Citeseer 148\u2013156.  Yoav Freund Robert\u00a0E Schapire 1996. Experiments with a new boosting algorithm. In icml Vol.\u00a096. Citeseer 148\u2013156."},{"key":"e_1_3_2_1_14_1","volume-title":"Extremely randomized trees. Machine learning 63, 1","author":"Geurts Pierre","year":"2006","unstructured":"Pierre Geurts , Damien Ernst , and Louis Wehenkel . 2006. Extremely randomized trees. Machine learning 63, 1 ( 2006 ), 3\u201342. Pierre Geurts, Damien Ernst, and Louis Wehenkel. 2006. Extremely randomized trees. Machine learning 63, 1 (2006), 3\u201342."},{"key":"e_1_3_2_1_15_1","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/acr2.11171","article-title":"DAS28-CRP cutoffs for high disease activity and remission are lower than DAS28-ESR in rheumatoid arthritis","volume":"2","author":"Greenmyer R","year":"2020","unstructured":"Jacob\u00a0 R Greenmyer , John\u00a0 M Stacy , Abe\u00a0 E Sahmoun , James\u00a0 R Beal , and Erdal Diri . 2020 . DAS28-CRP cutoffs for high disease activity and remission are lower than DAS28-ESR in rheumatoid arthritis . ACR Open Rheumatology 2 , 9 (2020), 507 \u2013 511 . Jacob\u00a0R Greenmyer, John\u00a0M Stacy, Abe\u00a0E Sahmoun, James\u00a0R Beal, and Erdal Diri. 2020. DAS28-CRP cutoffs for high disease activity and remission are lower than DAS28-ESR in rheumatoid arthritis. ACR Open Rheumatology 2, 9 (2020), 507\u2013511.","journal-title":"ACR Open Rheumatology"},{"key":"e_1_3_2_1_16_1","volume-title":"Obesity and reduction of the response rate to anti\u2013tumor necrosis factor \u03b1 in rheumatoid arthritis: an approach to a personalized medicine. Arthritis care & research 65, 1","author":"Gremese Elisa","year":"2013","unstructured":"Elisa Gremese , Antonio Carletto , Melissa Padovan , Fabiola Atzeni , Bernd Raffeiner , Anna\u00a0Rita Giardina , Ennio\u00a0Giulio Favalli , Gian\u00a0Luca Erre , Roberto Gorla , Mauro Galeazzi , 2013. Obesity and reduction of the response rate to anti\u2013tumor necrosis factor \u03b1 in rheumatoid arthritis: an approach to a personalized medicine. Arthritis care & research 65, 1 ( 2013 ), 94\u2013100. Elisa Gremese, Antonio Carletto, Melissa Padovan, Fabiola Atzeni, Bernd Raffeiner, Anna\u00a0Rita Giardina, Ennio\u00a0Giulio Favalli, Gian\u00a0Luca Erre, Roberto Gorla, Mauro Galeazzi, 2013. Obesity and reduction of the response rate to anti\u2013tumor necrosis factor \u03b1 in rheumatoid arthritis: an approach to a personalized medicine. Arthritis care & research 65, 1 (2013), 94\u2013100."},{"key":"e_1_3_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.41056"},{"key":"e_1_3_2_1_18_1","volume-title":"Proceedings of 3rd international conference on document analysis and recognition, Vol.\u00a01. IEEE, 278\u2013282","author":"Ho Tin\u00a0Kam","year":"1995","unstructured":"Tin\u00a0Kam Ho . 1995 . Random decision forests . In Proceedings of 3rd international conference on document analysis and recognition, Vol.\u00a01. IEEE, 278\u2013282 . Tin\u00a0Kam Ho. 1995. Random decision forests. In Proceedings of 3rd international conference on document analysis and recognition, Vol.\u00a01. IEEE, 278\u2013282."},{"key":"e_1_3_2_1_19_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11277-020-07166-9"},{"key":"e_1_3_2_1_20_1","volume-title":"Prediction of DAS28-ESR remission at 6 months by baseline variables in patients with rheumatoid arthritis treated with etanercept in Japanese population. Modern rheumatology 19, 5","author":"Iwamoto Naoki","year":"2009","unstructured":"Naoki Iwamoto , Atsushi Kawakami , Keita Fujikawa , Toshiyuki Aramaki , Shin-ya Kawashiri, Mami Tamai , Kazuhiko Arima , Kunihiro Ichinose , Makoto Kamachi , Satoshi Yamasaki , 2009. Prediction of DAS28-ESR remission at 6 months by baseline variables in patients with rheumatoid arthritis treated with etanercept in Japanese population. Modern rheumatology 19, 5 ( 2009 ), 488\u2013492. Naoki Iwamoto, Atsushi Kawakami, Keita Fujikawa, Toshiyuki Aramaki, Shin-ya Kawashiri, Mami Tamai, Kazuhiko Arima, Kunihiro Ichinose, Makoto Kamachi, Satoshi Yamasaki, 2009. Prediction of DAS28-ESR remission at 6 months by baseline variables in patients with rheumatoid arthritis treated with etanercept in Japanese population. Modern rheumatology 19, 5 (2009), 488\u2013492."},{"key":"e_1_3_2_1_21_1","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1093\/rheumatology\/ker010","article-title":"The value of rheumatoid factor and anti-citrullinated protein antibodies as predictors of response to infliximab in rheumatoid arthritis: an exploratory study","volume":"50","author":"Klaasen Ruth","year":"2011","unstructured":"Ruth Klaasen , Tineke Cantaert , Carla\u00a0 A Wijbrandts , Christine Teitsma , Danielle\u00a0 M Gerlag , Theo\u00a0 A Out , Monique\u00a0 J de Nooijer , Dominique Baeten , and Paul\u00a0 P Tak . 2011 . The value of rheumatoid factor and anti-citrullinated protein antibodies as predictors of response to infliximab in rheumatoid arthritis: an exploratory study . Rheumatology 50 , 8 (2011), 1487 \u2013 1493 . Ruth Klaasen, Tineke Cantaert, Carla\u00a0A Wijbrandts, Christine Teitsma, Danielle\u00a0M Gerlag, Theo\u00a0A Out, Monique\u00a0J de Nooijer, Dominique Baeten, and Paul\u00a0P Tak. 2011. The value of rheumatoid factor and anti-citrullinated protein antibodies as predictors of response to infliximab in rheumatoid arthritis: an exploratory study. Rheumatology 50, 8 (2011), 1487\u20131493.","journal-title":"Rheumatology"},{"key":"e_1_3_2_1_22_1","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/art.30136","article-title":"Body mass index and clinical response to infliximab in rheumatoid arthritis","volume":"63","author":"Klaasen Ruth","year":"2011","unstructured":"Ruth Klaasen , Carla\u00a0 A Wijbrandts , Danielle\u00a0 M Gerlag , and Paul\u00a0 P Tak . 2011 . Body mass index and clinical response to infliximab in rheumatoid arthritis . Arthritis & Rheumatism 63 , 2 (2011), 359 \u2013 364 . Ruth Klaasen, Carla\u00a0A Wijbrandts, Danielle\u00a0M Gerlag, and Paul\u00a0P Tak. 2011. Body mass index and clinical response to infliximab in rheumatoid arthritis. Arthritis & Rheumatism 63, 2 (2011), 359\u2013364.","journal-title":"Arthritis & Rheumatism"},{"key":"e_1_3_2_1_23_1","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1007\/s00296-011-2033-5","article-title":"Impact of patient and disease characteristics on therapeutic success during adalimumab treatment of patients with rheumatoid arthritis: data from a German noninterventional observational study","volume":"32","author":"Kleinert Stefan","year":"2012","unstructured":"Stefan Kleinert , Hans-Peter Tony , Andreas Krause , Martin Feuchtenberger , Siegfried Wassenberg , Constanze Richter , Ekkehard R\u00f6ther , Wolfgang Spieler , Holger Gnann , and Bianca\u00a0 M Wittig . 2012 . Impact of patient and disease characteristics on therapeutic success during adalimumab treatment of patients with rheumatoid arthritis: data from a German noninterventional observational study . Rheumatology international 32 , 9 (2012), 2759 \u2013 2767 . Stefan Kleinert, Hans-Peter Tony, Andreas Krause, Martin Feuchtenberger, Siegfried Wassenberg, Constanze Richter, Ekkehard R\u00f6ther, Wolfgang Spieler, Holger Gnann, and Bianca\u00a0M Wittig. 2012. Impact of patient and disease characteristics on therapeutic success during adalimumab treatment of patients with rheumatoid arthritis: data from a German noninterventional observational study. Rheumatology international 32, 9 (2012), 2759\u20132767.","journal-title":"Rheumatology international"},{"key":"e_1_3_2_1_24_1","volume-title":"Deep learning. nature 521, 7553","author":"LeCun Yann","year":"2015","unstructured":"Yann LeCun , Yoshua Bengio , and Geoffrey Hinton . 2015. Deep learning. nature 521, 7553 ( 2015 ), 436\u2013444. Yann LeCun, Yoshua Bengio, and Geoffrey Hinton. 2015. Deep learning. nature 521, 7553 (2015), 436\u2013444."},{"key":"e_1_3_2_1_25_1","volume-title":"Proceedings of the AutoML Workshop at ICML, Vol.\u00a02020","author":"LeDell Erin","year":"2020","unstructured":"Erin LeDell and Sebastien Poirier . 2020 . H2o automl: Scalable automatic machine learning . In Proceedings of the AutoML Workshop at ICML, Vol.\u00a02020 . Erin LeDell and Sebastien Poirier. 2020. H2o automl: Scalable automatic machine learning. In Proceedings of the AutoML Workshop at ICML, Vol.\u00a02020."},{"key":"e_1_3_2_1_26_1","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1136\/ard.2006.063834","article-title":"Disease Activity Score 28 (DAS28) using C-reactive protein underestimates disease activity and overestimates EULAR response criteria compared with DAS28 using erythrocyte sedimentation rate in a large observational cohort of rheumatoid arthritis patients in Japan","volume":"66","author":"Matsui Toshihiro","year":"2007","unstructured":"Toshihiro Matsui , Yoshiaki Kuga , Atsushi Kaneko , Jinju Nishino , Yoshito Eto , Noriyuki Chiba , Masayuki Yasuda , Koichiro Saisho , Kota Shimada , and Shigeto Tohma . 2007 . Disease Activity Score 28 (DAS28) using C-reactive protein underestimates disease activity and overestimates EULAR response criteria compared with DAS28 using erythrocyte sedimentation rate in a large observational cohort of rheumatoid arthritis patients in Japan . Annals of the rheumatic diseases 66 , 9 (2007), 1221 \u2013 1226 . Toshihiro Matsui, Yoshiaki Kuga, Atsushi Kaneko, Jinju Nishino, Yoshito Eto, Noriyuki Chiba, Masayuki Yasuda, Koichiro Saisho, Kota Shimada, and Shigeto Tohma. 2007. Disease Activity Score 28 (DAS28) using C-reactive protein underestimates disease activity and overestimates EULAR response criteria compared with DAS28 using erythrocyte sedimentation rate in a large observational cohort of rheumatoid arthritis patients in Japan. Annals of the rheumatic diseases 66, 9 (2007), 1221\u20131226.","journal-title":"Annals of the rheumatic diseases"},{"key":"e_1_3_2_1_27_1","doi-asserted-by":"publisher","DOI":"10.1002\/0471722073"},{"key":"e_1_3_2_1_28_1","doi-asserted-by":"crossref","first-page":"813","DOI":"10.3109\/14397595.2016.1168536","article-title":"A novel method predicting clinical response using only background clinical data in RA patients before treatment with infliximab","volume":"26","author":"Miyoshi Fumihiko","year":"2016","unstructured":"Fumihiko Miyoshi , Kyoko Honne , Seiji Minota , Masato Okada , Noriyoshi Ogawa , and Toshihide Mimura . 2016 . A novel method predicting clinical response using only background clinical data in RA patients before treatment with infliximab . Modern Rheumatology 26 , 6 (2016), 813 \u2013 816 . Fumihiko Miyoshi, Kyoko Honne, Seiji Minota, Masato Okada, Noriyoshi Ogawa, and Toshihide Mimura. 2016. A novel method predicting clinical response using only background clinical data in RA patients before treatment with infliximab. Modern Rheumatology 26, 6 (2016), 813\u2013816.","journal-title":"Modern Rheumatology"},{"key":"e_1_3_2_1_29_1","volume-title":"Gradient boosting machines, a tutorial. Frontiers in neurorobotics 7","author":"Natekin Alexey","year":"2013","unstructured":"Alexey Natekin and Alois Knoll . 2013. Gradient boosting machines, a tutorial. Frontiers in neurorobotics 7 ( 2013 ), 21. Alexey Natekin and Alois Knoll. 2013. Gradient boosting machines, a tutorial. Frontiers in neurorobotics 7 (2013), 21."},{"key":"e_1_3_2_1_30_1","volume-title":"Are biologics more effective than classical disease-modifying antirheumatic drugs?Arthritis research & therapy 10, 5","author":"Nurmohamed T","year":"2008","unstructured":"Michael\u00a0 T Nurmohamed and Ben\u00a0 AC Dijkmans . 2008. Are biologics more effective than classical disease-modifying antirheumatic drugs?Arthritis research & therapy 10, 5 ( 2008 ), 1\u20133. Michael\u00a0T Nurmohamed and Ben\u00a0AC Dijkmans. 2008. Are biologics more effective than classical disease-modifying antirheumatic drugs?Arthritis research & therapy 10, 5 (2008), 1\u20133."},{"key":"e_1_3_2_1_31_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2474-15-113","article-title":"Design characteristics of the CORRONA CERTAIN study: a comparative effectiveness study of biologic agents for rheumatoid arthritis patients","volume":"15","author":"Pappas A","year":"2014","unstructured":"Dimitrios\u00a0 A Pappas , Joel\u00a0 M Kremer , George Reed , Jeffrey\u00a0 D Greenberg , and Jeffrey\u00a0 R Curtis . 2014 . Design characteristics of the CORRONA CERTAIN study: a comparative effectiveness study of biologic agents for rheumatoid arthritis patients . BMC Musculoskeletal Disorders 15 , 1 (2014), 1 \u2013 10 . Dimitrios\u00a0A Pappas, Joel\u00a0M Kremer, George Reed, Jeffrey\u00a0D Greenberg, and Jeffrey\u00a0R Curtis. 2014. Design characteristics of the CORRONA CERTAIN study: a comparative effectiveness study of biologic agents for rheumatoid arthritis patients. BMC Musculoskeletal Disorders 15, 1 (2014), 1\u201310.","journal-title":"BMC Musculoskeletal Disorders"},{"key":"e_1_3_2_1_32_1","volume-title":"Scikit-learn: Machine learning in Python. the Journal of machine Learning research 12","author":"Pedregosa Fabian","year":"2011","unstructured":"Fabian Pedregosa , Ga\u00ebl Varoquaux , Alexandre Gramfort , Vincent Michel , Bertrand Thirion , Olivier Grisel , Mathieu Blondel , Peter Prettenhofer , Ron Weiss , Vincent Dubourg , 2011 . Scikit-learn: Machine learning in Python. the Journal of machine Learning research 12 (2011), 2825\u20132830. Fabian Pedregosa, Ga\u00ebl Varoquaux, Alexandre Gramfort, Vincent Michel, Bertrand Thirion, Olivier Grisel, Mathieu Blondel, Peter Prettenhofer, Ron Weiss, Vincent Dubourg, 2011. Scikit-learn: Machine learning in Python. the Journal of machine Learning research 12 (2011), 2825\u20132830."},{"key":"e_1_3_2_1_33_1","volume-title":"Crowdsourcing genetic prediction of clinical utility in the Rheumatoid Arthritis Responder Challenge. Nature genetics 45, 5","author":"Plenge M","year":"2013","unstructured":"Robert\u00a0 M Plenge , Jeffrey\u00a0 D Greenberg , Lara\u00a0 M Mangravite , Jonathan\u00a0 MJ Derry , Eli\u00a0 A Stahl , Marieke\u00a0 JH Coenen , Anne Barton , Leonid Padyukov , Lars Klareskog , Peter\u00a0 K Gregersen , 2013. Crowdsourcing genetic prediction of clinical utility in the Rheumatoid Arthritis Responder Challenge. Nature genetics 45, 5 ( 2013 ), 468\u2013469. Robert\u00a0M Plenge, Jeffrey\u00a0D Greenberg, Lara\u00a0M Mangravite, Jonathan\u00a0MJ Derry, Eli\u00a0A Stahl, Marieke\u00a0JH Coenen, Anne Barton, Leonid Padyukov, Lars Klareskog, Peter\u00a0K Gregersen, 2013. Crowdsourcing genetic prediction of clinical utility in the Rheumatoid Arthritis Responder Challenge. Nature genetics 45, 5 (2013), 468\u2013469."},{"key":"e_1_3_2_1_34_1","volume-title":"The strength of weak learnability. Machine learning 5, 2","author":"Schapire E","year":"1990","unstructured":"Robert\u00a0 E Schapire . 1990. The strength of weak learnability. Machine learning 5, 2 ( 1990 ), 197\u2013227. Robert\u00a0E Schapire. 1990. The strength of weak learnability. Machine learning 5, 2 (1990), 197\u2013227."},{"key":"e_1_3_2_1_35_1","volume-title":"Crowdsourced assessment of common genetic contribution to predicting anti-TNF treatment response in rheumatoid arthritis. Nature communications 7, 1","author":"Sieberts K","year":"2016","unstructured":"Solveig\u00a0 K Sieberts , Fan Zhu , Javier Garc\u00eda-Garc\u00eda , Eli Stahl , Abhishek Pratap , Gaurav Pandey , Dimitrios Pappas , Daniel Aguilar , Bernat Anton , Jaume Bonet , 2016. Crowdsourced assessment of common genetic contribution to predicting anti-TNF treatment response in rheumatoid arthritis. Nature communications 7, 1 ( 2016 ), 1\u201310. Solveig\u00a0K Sieberts, Fan Zhu, Javier Garc\u00eda-Garc\u00eda, Eli Stahl, Abhishek Pratap, Gaurav Pandey, Dimitrios Pappas, Daniel Aguilar, Bernat Anton, Jaume Bonet, 2016. Crowdsourced assessment of common genetic contribution to predicting anti-TNF treatment response in rheumatoid arthritis. Nature communications 7, 1 (2016), 1\u201310."},{"key":"e_1_3_2_1_36_1","volume-title":"PL Van\u00a0Riel, LA Theunisse, Evelien\u00a0W Lubberts, Miek\u00a0A van Leeuwen, Martin\u00a0H van Rijswijk, and LB Van\u00a0de Putte.","author":"Van\u00a0der Heijde DM","year":"1990","unstructured":"DM Van\u00a0der Heijde , Martin\u00a0A van\u2019t Hof , PL Van\u00a0Riel, LA Theunisse, Evelien\u00a0W Lubberts, Miek\u00a0A van Leeuwen, Martin\u00a0H van Rijswijk, and LB Van\u00a0de Putte. 1990 . Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score.Annals of the rheumatic diseases 49, 11 (1990), 916\u2013920. DM Van\u00a0der Heijde, Martin\u00a0A van\u2019t Hof, PL Van\u00a0Riel, LA Theunisse, Evelien\u00a0W Lubberts, Miek\u00a0A van Leeuwen, Martin\u00a0H van Rijswijk, and LB Van\u00a0de Putte. 1990. Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score.Annals of the rheumatic diseases 49, 11 (1990), 916\u2013920."},{"key":"e_1_3_2_1_37_1","doi-asserted-by":"crossref","unstructured":"Mark\u00a0J Van\u00a0der Laan Eric\u00a0C Polley and Alan\u00a0E Hubbard. 2007. Super learner. Statistical applications in genetics and molecular biology 6 1(2007).  Mark\u00a0J Van\u00a0der Laan Eric\u00a0C Polley and Alan\u00a0E Hubbard. 2007. Super learner. Statistical applications in genetics and molecular biology 6 1(2007).","DOI":"10.2202\/1544-6115.1309"},{"key":"e_1_3_2_1_38_1","first-page":"315","article-title":"The early clinical course of infliximab treatment in rheumatoid arthritis: results from the REMARK observational study","volume":"32","author":"Westhovens Rene","year":"2014","unstructured":"Rene Westhovens , Ronald\u00a0 F van Vollenhoven , Dimitrios\u00a0 T Boumpas , Marek Brzosko , Karin Svensson , Olav Bjorneboe , Cees\u00a0 M Meeuwisse , Shankar Srinivasan , Philippe Gaudin , Josef\u00a0 S Smolen , 2014 . The early clinical course of infliximab treatment in rheumatoid arthritis: results from the REMARK observational study . Clin Exp Rheumatol 32 , 3 (2014), 315 \u2013 323 . Rene Westhovens, Ronald\u00a0F van Vollenhoven, Dimitrios\u00a0T Boumpas, Marek Brzosko, Karin Svensson, Olav Bjorneboe, Cees\u00a0M Meeuwisse, Shankar Srinivasan, Philippe Gaudin, Josef\u00a0S Smolen, 2014. The early clinical course of infliximab treatment in rheumatoid arthritis: results from the REMARK observational study. Clin Exp Rheumatol 32, 3 (2014), 315\u2013323.","journal-title":"Clin Exp Rheumatol"}],"event":{"name":"ICBBE 2022: 2022 9th International Conference on Biomedical and Bioinformatics Engineering","location":"Kyoto Japan","acronym":"ICBBE 2022"},"container-title":["Proceedings of the 2022 9th International Conference on Biomedical and Bioinformatics Engineering"],"original-title":[],"link":[{"URL":"https:\/\/dl.acm.org\/doi\/10.1145\/3574198.3574221","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/dl.acm.org\/doi\/pdf\/10.1145\/3574198.3574221","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T18:08:26Z","timestamp":1750183706000},"score":1,"resource":{"primary":{"URL":"https:\/\/dl.acm.org\/doi\/10.1145\/3574198.3574221"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,10]]},"references-count":38,"alternative-id":["10.1145\/3574198.3574221","10.1145\/3574198"],"URL":"https:\/\/doi.org\/10.1145\/3574198.3574221","relation":{},"subject":[],"published":{"date-parts":[[2022,11,10]]},"assertion":[{"value":"2023-03-15","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}